206 related articles for article (PubMed ID: 17261616)
1. Impact of the molecular form of immunoglobulin A on functional activity in defense against Streptococcus pneumoniae.
Fasching CE; Grossman T; Corthésy B; Plaut AG; Weiser JN; Janoff EN
Infect Immun; 2007 Apr; 75(4):1801-10. PubMed ID: 17261616
[TBL] [Abstract][Full Text] [Related]
2. Killing of Streptococcus pneumoniae by capsular polysaccharide-specific polymeric IgA, complement, and phagocytes.
Janoff EN; Fasching C; Orenstein JM; Rubins JB; Opstad NL; Dalmasso AP
J Clin Invest; 1999 Oct; 104(8):1139-47. PubMed ID: 10525053
[TBL] [Abstract][Full Text] [Related]
3. In vitro comparison of the biologic activities of monoclonal monomeric IgA, polymeric IgA, and secretory IgA.
Renegar KB; Jackson GD; Mestecky J
J Immunol; 1998 Feb; 160(3):1219-23. PubMed ID: 9570537
[TBL] [Abstract][Full Text] [Related]
4. Pneumococcal IgA1 protease subverts specific protection by human IgA1.
Janoff EN; Rubins JB; Fasching C; Charboneau D; Rahkola JT; Plaut AG; Weiser JN
Mucosal Immunol; 2014 Mar; 7(2):249-56. PubMed ID: 23820749
[TBL] [Abstract][Full Text] [Related]
5. Resistance of normal serum IgA and secretory IgA to bacterial IgA proteases: evidence for the presence of enzyme-neutralizing antibodies in both serum and secretory IgA, and also in serum IgG.
Kobayashi K; Fujiyama Y; Hagiwara K; Kondoh H
Microbiol Immunol; 1987; 31(11):1097-106. PubMed ID: 3127662
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin A Glycosylation and Its Role in Disease.
Hansen AL; Reily C; Novak J; Renfrow MB
Exp Suppl; 2021; 112():433-477. PubMed ID: 34687019
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Streptococcus mutans adherence to saliva-coated hydroxyapatite by human secretory immunoglobulin A (S-IgA) antibodies to cell surface protein antigen I/II: reversal by IgA1 protease cleavage.
Hajishengallis G; Nikolova E; Russell MW
Infect Immun; 1992 Dec; 60(12):5057-64. PubMed ID: 1333448
[TBL] [Abstract][Full Text] [Related]
8. Isolation and Characterization of Human Monoclonal Antibodies to Pneumococcal Capsular Polysaccharide 3.
Babb R; Doyle CR; Pirofski LA
Microbiol Spectr; 2021 Dec; 9(3):e0144621. PubMed ID: 34756090
[TBL] [Abstract][Full Text] [Related]
9. Monomeric immunoglobulin A protects glomerulus against polymeric immunoglobulin A immune complex in experimental immunoglobulin A nephropathy.
Chen A; Sheu LF; Ding SL; Lee WH
Lab Invest; 1996 Apr; 74(4):737-46. PubMed ID: 8606484
[TBL] [Abstract][Full Text] [Related]
10. Prolonged and preferential production of polymeric immunoglobulin A in response to Streptococcus pneumoniae capsular polysaccharides.
Johnson S; Opstad NL; Douglas JM; Janoff EN
Infect Immun; 1996 Oct; 64(10):4339-44. PubMed ID: 8926108
[TBL] [Abstract][Full Text] [Related]
11. Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy.
Oortwijn BD; Roos A; Royle L; van Gijlswijk-Janssen DJ; Faber-Krol MC; Eijgenraam JW; Dwek RA; Daha MR; Rudd PM; van Kooten C
J Am Soc Nephrol; 2006 Dec; 17(12):3529-39. PubMed ID: 17050773
[TBL] [Abstract][Full Text] [Related]
12. Human plasma-derived polymeric IgA and IgM antibodies associate with secretory component to yield biologically active secretory-like antibodies.
Longet S; Miled S; Lötscher M; Miescher SM; Zuercher AW; Corthésy B
J Biol Chem; 2013 Feb; 288(6):4085-94. PubMed ID: 23250751
[TBL] [Abstract][Full Text] [Related]
13. Identification of a human immunodominant B-cell epitope within the immunoglobulin A1 protease of Streptococcus pneumoniae.
De Paolis F; Beghetto E; Spadoni A; Montagnani F; Felici F; Oggioni MR; Gargano N
BMC Microbiol; 2007 Dec; 7():113. PubMed ID: 18088426
[TBL] [Abstract][Full Text] [Related]
14. Antibody blocks acquisition of bacterial colonization through agglutination.
Roche AM; Richard AL; Rahkola JT; Janoff EN; Weiser JN
Mucosal Immunol; 2015 Jan; 8(1):176-85. PubMed ID: 24962092
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the cross-reactive anti-influenza neutralizing activity of polymeric and monomeric IgA monoclonal antibodies.
Tanimoto T; Haredy AM; Takenaka N; Tamura S; Okuno Y; Mori Y; Yamanishi K; Okamoto S
Viral Immunol; 2012 Oct; 25(5):433-9. PubMed ID: 22985289
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulins in nasal secretions of healthy humans: structural integrity of secretory immunoglobulin A1 (IgA1) and occurrence of neutralizing antibodies to IgA1 proteases of nasal bacteria.
Kirkeby L; Rasmussen TT; Reinholdt J; Kilian M
Clin Diagn Lab Immunol; 2000 Jan; 7(1):31-9. PubMed ID: 10618273
[TBL] [Abstract][Full Text] [Related]
17. Antibody-enhanced pneumococcal adherence requires IgA1 protease.
Weiser JN; Bae D; Fasching C; Scamurra RW; Ratner AJ; Janoff EN
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4215-20. PubMed ID: 12642661
[TBL] [Abstract][Full Text] [Related]
18. Induction of functional secretory IgA responses in breast milk, by pneumococcal capsular polysaccharides.
Finn A; Zhang Q; Seymour L; Fasching C; Pettitt E; Janoff EN
J Infect Dis; 2002 Nov; 186(10):1422-9. PubMed ID: 12404157
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory activity of human IgA antibodies and their Fab alpha fragments: inhibition of IgG-mediated complement activation.
Russell MW; Reinholdt J; Kilian M
Eur J Immunol; 1989 Dec; 19(12):2243-9. PubMed ID: 2606139
[TBL] [Abstract][Full Text] [Related]
20. Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal capsular polysaccharides in children.
Simell B; Kilpi TM; Käyhty H
J Infect Dis; 2002 Oct; 186(8):1106-14. PubMed ID: 12355361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
